Study Type
Interventional - Procedure
ongoing
RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer.
The primary objective of RADICAL PC1 is to determine the prevalence of cardiovascular risk factors and disease, and the incidence of major adverse cardiovascular events in men with prostate cancer and in particular men treated with Androgen Deprivation Therapy.
RADICAL PC2 is a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer.
The primary objective of RADICAL PC2 is to determine whether a systematic cardiovascular and lifestyle risk factor modification strategy reduces the risk of major adverse cardiovascular events in men with a new diagnosis of prostate cancer or who are commencing Androgen Deprivation Therapy for the first time.
Study Design
Prospective cohort; RCT
NO. of Countries
1
NO. of Sites
20
NO. of Participants
4600
Study Period
2015 - 2025
Sponsor
PHRI
Darryl Leong
Scientist
Darryl Leong
Scientist
Darryl Leong is a Scientist at PHRI, Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program, Associate Professor, Department of Medicine (Cardiology), McMaster University, and Staff Cardiologist at Hamilton Health Sciences. He has methodological expertise in clinical epidemiology and clinical trials, and content expertise in physical frailty, echocardiography, and cardio-oncology. His research is supported by the CIHR, and he has published more than 100 manuscripts including all the leading internal medical and cardiovascular journals.
He graduated from the University of Adelaide Medical School with Deans Listing and Honours for academic excellence, completed his cardiology training, Doctor of Philosophy, Master of Public Health, and Master of Biostatistics degrees at the University of Adelaide in Australia, and completed a post-doctorate fellowship in cardiovascular imaging at the Leiden University Medical Centre in The Netherlands, before re-locating to Canada.
PJ Devereaux
Senior Scientist
PJ Devereaux
Senior Scientist
PJ Devereaux is Senior Scientific Lead, Perioperative and Surgery, PHRI, Professor and University Scholar in the Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine at McMaster University, and Director of the Division of Cardiology at McMaster.
The focus of his clinic research is vascular complications around the time of surgery, leading several large, international RCTs and observational studies addressing this issue. He has published more than 250 peer-reviewed papers and more than 50 book chapters and editorials. He is supported by a Tier 1 Canadian Research Chair in Perioperative Medicine, and holds the Yusuf Chair in Cardiology at McMaster University.
Sumathy Rangarajan
Program Director
Sumathy Rangarajan
Program Director
Sumathy Rangarajan has been Program Director, Global Health, since 2016, preceded by many years’ service at PHRI in other roles. She oversees the PURE study team, as well as the INVICTUS rheumatic AF treatment trial, the CANPWR pediatric weight management registry, and others.
She holds both a Bachelor of Science Degree and a Master of Science degree from Pune University in India.
Prostate Cancer Canada
Canadian Cancer Society
Hamilton Health Sciences
ongoing
RADICAL PC-Observational
Cancer Survivorship
RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate...
